SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-104264
Filing Date
2013-03-13
Accepted
2013-03-13 08:02:13
Documents
4
Period of Report
2013-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d499989d8k.htm 8-K 16559
2 EX-99.1 d499989dex991.htm EX-99.1 101817
3 GRAPHIC g499989g91q22.jpg GRAPHIC 4203
4 GRAPHIC g499989g99g58.jpg GRAPHIC 2867
  Complete submission text file 0001193125-13-104264.txt   129691
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 13686023
SIC: 2834 Pharmaceutical Preparations